sales@angenesci.com
Login | Register
logo
Structures Search
Home Aminos 1-Propanol, 3-(dibutylamino)-, 1-(4-aminobenzoate)

1-Propanol, 3-(dibutylamino)-, 1-(4-aminobenzoate)

CAS No.:
149-16-6
Catalog Number:
AG001LCC
Molecular Formula:
C18H30N2O2
Molecular Weight:
306.4430
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
100mg
99%
1 week
United States
$157
- +
Product Description
Catalog Number:
AG001LCC
Chemical Name:
1-Propanol, 3-(dibutylamino)-, 1-(4-aminobenzoate)
CAS Number:
149-16-6
Molecular Formula:
C18H30N2O2
Molecular Weight:
306.4430
MDL Number:
MFCD00056117
IUPAC Name:
3-(dibutylamino)propyl 4-aminobenzoate
InChI:
InChI=1S/C18H30N2O2/c1-3-5-12-20(13-6-4-2)14-7-15-22-18(21)16-8-10-17(19)11-9-16/h8-11H,3-7,12-15,19H2,1-2H3
InChI Key:
HQFWVSGBVLEQGA-UHFFFAOYSA-N
SMILES:
CCCCN(CCCC)CCCOC(=O)c1ccc(cc1)N
EC Number:
205-734-7
UNII:
Z84S23CGJJ
NSC Number:
758632
Properties
Complexity:
281  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
306.231g/mol
Formal Charge:
0
Heavy Atom Count:
22  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
306.45g/mol
Monoisotopic Mass:
306.231g/mol
Rotatable Bond Count:
12  
Topological Polar Surface Area:
55.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.5  
Literature
Title Journal
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Solubility-excipient classification gradient maps. Pharmaceutical research 20070301
PAMPA - excipient classification gradient map. Pharmaceutical research 20061101
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Managing patients with local anesthetic complications using alternative methods. Pennsylvania dental journal 20020101
Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. Free radical biology & medicine 20010415
Keratitis from misuse of corneal anesthetics. The New England journal of medicine 19680822
Properties